Search
IMMU-114
go.drugbank.com/drugs/DB18458InvestigationalIMMU-114 is antibody-drug conjugate consisting of humanized anti-HLA-DR IgG4 monoclonal antibody specific for alpha-chain linked to SN-38 via a CL2A linker.
ALT-P1
go.drugbank.com/drugs/DB18485InvestigationalIt is under investigation for the treatment of growth hormone deficiency.
RD13-02
go.drugbank.com/drugs/DB27110InvestigationalRD13-02 is under investigation in clinical trial NCT05923541 (RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies).
Estrone
go.drugbank.com/drugs/DB00655ApprovedIt is produced in vivo from androstenedione or from testosterone via estradiol.
Tosylchloramide
go.drugbank.com/drugs/DB14708InvestigationalIt is not stable in the water dissolved form.
Categories: Compounds used in a research, industrial, or household settingNemonoxacin
go.drugbank.com/drugs/DB06600InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseTA-CIN
go.drugbank.com/drugs/DB05809InvestigationalTA-CIN is a subunit vaccine comprising L2/E6/E7 proteins from Human Papillomavirus (HPV16), designed to generate a strong cellular immune response against HPV-infected cells.
VPM4001
go.drugbank.com/drugs/DB05089ExperimentalVPM4001 is an allogeneic vaccine for treatment of prostate carcinoma.
HNM01
go.drugbank.com/drugs/DB06531ExperimentalIt entered Phase 1 clinical trials for the treatment of HIV infections but was discontinued during this phase
Lucanthone
go.drugbank.com/drugs/DB04967InvestigationalOne of the schistosomicides, it has been replaced largely by hycanthone and more recently praziquantel. (From Martindale The Extrapharmacopoeia, 30th ed., p46). It is currently being tested as a radiation sensitizer.